Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

Affiliations

• ¹ Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
• ² Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
• ³ Department of Hematology, Yokohama City University Medical Center, Kanagawa, Japan.
• ⁴ Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
• ⁵ Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
• ⁶ Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
• ⁷ Department of Hematology, Chiba University Hospital, Chiba, Japan.
• ⁸ Department of Hematology, International University of Health and Welfare Narita Hospital, Chiba, Japan.
• ⁹ Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan.
• ¹⁰ Department of Hematology, Aoba Municipal Hospital, Chiba, Japan.
• ¹¹ Division of Hematology, Jichi Medical University, Tochigi, Japan.
• ¹² Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan.
• ¹³ Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
• ¹⁴ Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
• ¹⁵ Department of Medicine, Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
• ¹⁶ Division of Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.
• ¹⁷ Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. ycanda-tky@umin.ac.jp.
• ¹⁸ Division of Hematology, Jichi Medical University, Tochigi, Japan. ycanda-tky@umin.ac.jp.